Plasma Biomarkers C-RAC, ICORG 12-27, V1
Identification of Plasma Biomarkers in Early Detection of Colorectal Adenocarcinoma Recurrence (C-RAC Plasma Biomarker Study)
Sponsor: Cancer Trials Ireland
Terminated
As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up.
Other terminated trials from Cancer Trials Ireland
Other Colorectal Cancer trials with similar outcome
This observational or N/A phase trial investigates Colorectal Cancer and is currently terminated or withdrawn. Cancer Trials Ireland leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Aug 2025 — Present [monthly]
Terminated
-
Sep 2024 — Aug 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2023 — Jul 2024 [monthly]
Terminated
-
Feb 2022 — May 2023 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2022 [monthly]
Active Not Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2018 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Trials Ireland
For direct contact, visit the study record on ClinicalTrials.gov .